Search for COVID19 targets
You are searching for: MERS
T99041 Target Info |
Target Name | HUMAN dipeptidyl peptidase 4 (DPP-4) | |
---|---|---|---|
Target type | Target in Phase 3 Trial | ||
Disease | Coronavirus Disease 2019 (COVID-19); Middle East Respiratory Syndrome (MERS) | ||
Drugs | Linagliptin | Drug Info |
T88015 Target Info |
Target Name | COVID-19 3C-like protease (3CLpro) | |
---|---|---|---|
Target type | Target in Phase 3 Trial | ||
Disease | Coronavirus Disease 2019 (COVID-19) | ||
Drugs | Lopinavir + ritonavir | Drug Info |
T87325 Target Info |
Target Name | COVID-19 papain-like proteinase (PL-PRO) | |
---|---|---|---|
Target type | Target in Phase 3 Trial | ||
Disease | Coronavirus Disease 2019 (COVID-19) | ||
Drugs | Isotretinoin | Drug Info |
T94918 Target Info |
Target Name | COVID-19 RNA-directed RNA polymerase (RdRp) | |
---|---|---|---|
Target type | Target in Phase 3 Trial | ||
Disease | Coronavirus Disease 2019 (COVID-19) | ||
Drugs | Favipiravir | Drug Info |
T00158 Target Info |
Target Name | HUMAN glycosylation of host receptor (GHR) | |
---|---|---|---|
Target type | Target in Phase 3 Trial | ||
Disease | Coronavirus Disease 2019 (COVID-19) | ||
Drugs | Hydroxychloroquine | Drug Info |
T18226 Target Info |
Target Name | HUMAN clathrin-mediated endocytosis (RME) | |
---|---|---|---|
Target type | Target in Phase 3 Trial | ||
Disease | Coronavirus Disease 2019 (COVID-19); Middle East Respiratory Syndrome (MERS) | ||
Drugs | Chlorpromazine | Drug Info |
T00145 Target Info |
Target Name | HUMAN pH-dependent viral fusion/replication (pH-DVF/R) | |
---|---|---|---|
Target type | Target in Phase 3 Trial | ||
Disease | Coronavirus Disease 2019 (COVID-19) | ||
Drugs | Hydroxychloroquine | Drug Info |
T99009 Target Info |
Target Name | HUMAN dihydroorotate dehydrogenase (DHODH) | |
---|---|---|---|
Target type | Target in Phase 2 Trial | ||
Disease | Coronavirus Disease 2019 (COVID-19); Middle East Respiratory Syndrome (MERS) | ||
Drugs | IMU-838 | Drug Info |
T87374 Target Info |
Target Name | COVID-19 spike glycoprotein (S) | |
---|---|---|---|
Target type | Target in Phase 2 Trial | ||
Disease | Coronavirus Disease 2019 (COVID-19) | ||
Drugs | Nafamostat | Drug Info |
T99908 Target Info |
Target Name | HUMAN transmembrane protease serine 2 (TMPRSS2) | |
---|---|---|---|
Target type | Target in Phase 2 Trial | ||
Disease | Coronavirus Disease 2019 (COVID-19); Middle East Respiratory Syndrome (MERS) | ||
Drugs | Camostat mesylate | Drug Info |
Pagination
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.